DA-7503
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DA-7503, covering 2024-04-30 to 2024-04-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly Participants [Phase 1]